Blossom Suravi Raychaudhuri, MD
Assistant Professor
Clinical Research Division, Fred Hutch
Dr. Blossom Raychaudhuri is a hematologist-oncologist whose research focuses on the development of clinical trials of novel treatment and prognostic strategies for acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). She has experience in both Phase 1 and Phase 2 clinical trials for both relapsed/refractory AML and MDS and was previously a chief fellow at the Fred Hutch/University of Washington Hematology-Oncology Fellowship Program.
Other Appointments & Affiliations
Physician, Fred HutchPhysician
Fred Hutch
Assistant Professor
Division of Hematology and Oncology, University of Washington School of Medicine
Education
Fellowship, Hematology/Oncology, Fred Hutch/University of Washington, 2025
Residency, Internal Medicine, Stanford University, 2022
MD, University of California, San Francisco, 2019
BS, Chemical Biology, University of California, Berkeley, 2014
Board Certification
Internal Medicine, 2019, American Board of Internal Medicine
Clinical Expertise
Acute myeloid leukemia
Myelodysplastic syndrome
Diseases Researched
Acute myeloid leukemia
Myelodysplastic syndrome